Arden Trust CO Vertex Pharmaceuticals Inc Transaction History

Arden Trust CO

$683 Million
Q2 2024

A detailed history of Arden Trust CO transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Arden Trust CO holds 2,370 shares of VRTX stock, worth $1.1 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

2,370

Previous 2,373 0.13%

Holding current value

$1.1 Million

Previous $991,000 12.01%

% of portfolio

0.16%

Previous 0.14%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 09, 2024	SELL	$392.81 - $485.53 $1,178 - $1,456	-3 Reduced 0.13%	2,370 $1.11 Million
Q4 2023 Jan 04, 2024	SELL	$343.0 - $410.68 $164,640 - $197,126	-480 Reduced 16.82%	2,373 $965,000
Q3 2023 Oct 10, 2023	SELL	$338.18 - $362.46 $222,522 - $238,498	-658 Reduced 18.74%	2,853 $992,000
Q2 2023 Jul 14, 2023	SELL	$314.42 - $351.91 $885,092 - $990,626	-2,815 Reduced 44.5%	3,511 $1.24 Million
Q1 2023 Apr 14, 2023	SELL	$283.23 - $323.1 $336,194 - $383,519	-1,187 Reduced 15.8%	6,326 $1.99 Million
Q4 2022 Jan 20, 2023	SELL	$285.76 - $321.48 $40,006 - $45,007	-140 Reduced 1.83%	7,513 $0
Q3 2022 Oct 20, 2022	SELL	$273.83 - $305.53 $267,258 - $298,197	-976 Reduced 11.31%	7,653 $2.22 Million
Q2 2022 Jul 12, 2022	SELL	$234.96 - $292.55 $386,039 - $480,659	-1,643 Reduced 15.99%	8,629 $2.43 Million
Q1 2022 Apr 11, 2022	SELL	$221.42 - $260.97 $58,233 - $68,635	-263 Reduced 2.5%	10,272 $2.68 Million
Q4 2021 Jan 24, 2022	SELL	$177.01 - $223.45 $794,951 - $1 Million	-4,491 Reduced 29.89%	10,535 $2.31 Million
Q3 2021 Oct 12, 2021	BUY	$181.39 - $202.99 $16,325 - $18,269	90 Added 0.6%	15,026 $2.73 Million
Q2 2021 Jul 19, 2021	SELL	$187.49 - $221.1 $105,744 - $124,700	-564 Reduced 3.64%	14,936 $3.01 Million
Q1 2021 Apr 23, 2021	BUY	$207.02 - $241.31 $1.06 Million - $1.23 Million	5,107 Added 49.14%	15,500 $3.33 Million
Q4 2020 Jan 15, 2021	SELL	$207.01 - $276.09 $46,163 - $61,568	-223 Reduced 2.1%	10,393 $2.46 Million
Q3 2020 Oct 15, 2020	SELL	$255.65 - $303.1 $126,035 - $149,428	-493 Reduced 4.44%	10,616 $2.89 Million
Q2 2020 Jul 09, 2020	BUY	$225.48 - $295.8 $748,368 - $981,760	3,319 Added 42.61%	11,109 $3.23 Million
Q1 2020 Apr 16, 2020	SELL	$199.77 - $247.81 $11,586 - $14,372	-58 Reduced 0.74%	7,790 $1.85 Million
Q4 2019 Jan 17, 2020	SELL	$166.71 - $223.91 $122,698 - $164,797	-736 Reduced 8.57%	7,848 $1.72 Million
Q3 2019 Oct 09, 2019	SELL	$166.23 - $187.09 $8,145 - $9,167	-49 Reduced 0.57%	8,584 $1.45 Million
Q2 2019 Jul 23, 2019	BUY	$164.61 - $190.37 $1.42 Million - $1.64 Million	8,633 New	8,633 $1.58 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arden Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Arden Trust CO with notifications on news.

Account